Balance Sheet Data

Abbott Laboratories (ABT)

$ 125.35
+4.91 (+4.08%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 18,7759,6104,0864,1407,14813,574.8815,468.5517,626.3820,085.2322,887.07
Total Cash (%)
Account Receivables 3,2485,2495,1825,4256,4146,879.487,839.158,932.6910,178.7911,598.71
Account Receivables (%)
Inventories 2,4343,6013,7964,3165,0125,145.875,863.716,681.697,613.778,675.87
Inventories (%)
Accounts Payable 1,1782,4022,9753,2523,9463,607.824,111.104,684.595,338.086,082.73
Accounts Payable (%)
Capital Expenditure -1,121-1,135-1,394-1,638-2,177-2,011.46-2,292.05-2,611.79-2,976.13-3,391.30
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.